Holen Sie sich die Stockscreener-App
81.60
0.67%
-0.55
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$82.15
Offen:
$82.71
24-Stunden-Volumen:
8.54M
Relative Volume:
2.09
Marktkapitalisierung:
$39.67B
Einnahmen:
$6.13B
Nettoeinkommen (Verlust:
$272.21M
KGV:
147.80
EPS:
0.5521
Netto-Cashflow:
$1.38B
1W Leistung:
-2.73%
1M Leistung:
-7.42%
6M Leistung:
+2.11%
1J Leistung:
+30.14%
1-Tages-Spanne:
$81.02
$82.71
1-Wochen-Bereich:
$81.02
$85.02
52-Wochen-Spanne:
$61.76
$91.06
Ventas Inc Stock (VTR) Company Profile
Firmenname
Ventas Inc
Sektor
Telefon
(312) 660-3800
Adresse
300 N LASALLE STREET, CHICAGO, IL
Compare VTR vs WELL, DOC, OHI, AHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
VTR
Ventas Inc
|
81.60 | 39.67B | 6.13B | 272.21M | 1.38B | 0.5521 |
WELL
Welltower Inc
|
206.65 | 145.88B | 11.75B | 1.46B | 2.19B | -0.6014 |
DOC
Healthpeak Properties Inc
|
19.56 | 13.49B | 2.87B | 250.10M | 1.13B | 0.3188 |
OHI
Omega Healthcare Investors Inc
|
44.53 | 13.26B | 1.24B | 655.98M | 857.80M | 2.063 |
AHR
American Healthcare Reit Inc
|
46.52 | 9.62B | 2.37B | 101.67M | 169.19M | 0.5775 |
Ventas Inc Stock (VTR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-09 | Eingeleitet | Goldman | Buy |
| 2025-10-01 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2025-09-19 | Eingeleitet | UBS | Neutral |
| 2025-06-23 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2025-03-07 | Hochstufung | Argus | Hold → Buy |
| 2025-01-17 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2024-10-01 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-03-18 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2024-02-26 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2024-01-30 | Eingeleitet | Deutsche Bank | Buy |
| 2024-01-16 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-11-07 | Hochstufung | Wedbush | Neutral → Outperform |
| 2023-10-11 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2023-10-03 | Eingeleitet | Wedbush | Neutral |
| 2023-09-20 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2023-08-11 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-06-23 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2023-04-20 | Eingeleitet | Wells Fargo | Overweight |
| 2022-11-01 | Bestätigt | Credit Suisse | Outperform |
| 2022-11-01 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2022-10-10 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2022-06-30 | Hochstufung | Jefferies | Hold → Buy |
| 2022-06-23 | Eingeleitet | Credit Suisse | Outperform |
| 2022-06-03 | Eingeleitet | CapitalOne | Overweight |
| 2022-05-18 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2022-03-11 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2022-03-11 | Hochstufung | BofA Securities | Neutral → Buy |
| 2022-02-01 | Eingeleitet | Credit Suisse | Neutral |
| 2022-01-20 | Hochstufung | Mizuho | Neutral → Buy |
| 2021-12-14 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-11-22 | Herabstufung | SMBC Nikko | Outperform → Neutral |
| 2021-10-04 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2021-09-23 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2021-09-07 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2021-08-26 | Hochstufung | BMO Capital Markets | Underperform → Market Perform |
| 2021-07-14 | Fortgesetzt | Mizuho | Neutral |
| 2021-06-15 | Eingeleitet | Wolfe Research | Outperform |
| 2021-06-11 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2021-05-13 | Hochstufung | KeyBanc Capital Markets | Underweight → Overweight |
| 2021-05-13 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2021-01-08 | Herabstufung | BMO Capital Markets | Market Perform → Underperform |
| 2021-01-06 | Eingeleitet | Robert W. Baird | Neutral |
| 2020-11-30 | Hochstufung | BofA Securities | Underperform → Buy |
| 2020-11-10 | Hochstufung | Jefferies | Underperform → Hold |
| 2020-09-08 | Herabstufung | Argus | Buy → Hold |
| 2020-09-02 | Fortgesetzt | Stifel | Hold |
| 2020-08-20 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2020-08-14 | Hochstufung | Evercore ISI | Underperform → In-line |
| 2020-08-14 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-06-15 | Herabstufung | Evercore ISI | In-line → Underperform |
| 2020-03-25 | Hochstufung | Raymond James | Mkt Perform → Strong Buy |
| 2020-03-23 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2020-03-10 | Herabstufung | Jefferies | Buy → Underperform |
| 2020-02-28 | Hochstufung | Raymond James | Underperform → Mkt Perform |
| 2020-01-22 | Herabstufung | Raymond James | Mkt Perform → Underperform |
| 2020-01-17 | Hochstufung | Jefferies | Hold → Buy |
| 2019-12-20 | Fortgesetzt | Mizuho | Neutral |
| 2019-12-10 | Herabstufung | Wells Fargo | Market Perform → Underperform |
| 2019-11-19 | Hochstufung | Argus | Hold → Buy |
| 2019-10-30 | Herabstufung | Stifel | Buy → Hold |
| 2019-10-28 | Herabstufung | CapitalOne | Overweight → Equal Weight |
| 2019-10-28 | Herabstufung | Citigroup | Buy → Neutral |
Alle ansehen
Ventas Inc Aktie (VTR) Neueste Nachrichten
Is Ventas stock outperforming the Dow? - MSN
Ventas StockThursday technical picture and trading levels - AD HOC NEWS
Trading the Move, Not the Narrative: (VTR) Edition - Stock Traders Daily
Scotiabank Adjusts Price Target on Ventas to $88 From $95, Maintains Sector Perform Rating - marketscreener.com
Ventas Inc (VTR) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Ventas Inc (VTR) Institutional Confidence - TradingKey
Ventas Inc (VTR) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Why Ventas’ Magnolia Court shows how senior living is changing quietly - AD HOC NEWS
Ventas Inc (VTR) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Ventas Inc (VTR) Valuation: PE, PB & Fair Value Analysis - TradingKey
Ventas Inc. stock outperforms competitors despite losses on the day - MarketWatch
Ventas Inc (VTR) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Ventas Inc (VTR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Ventas Inc (VTR) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Ventas (VTR) Receives Outperform Rating with $94 Price Target - GuruFocus
Ventas Announces General Counsel Transition and Interim Successor - The Globe and Mail
Ventas General Counsel Departs to Blackstone - Law.com
Ventas Inc. Stock (US92276F1003): REIT in focus as healthcare and senior housing demand grows - AD HOC NEWS
Is Ventas Stock Outperforming the Dow? - inkl
Deutsche Bank Lifts Price Target on Ventas to $100 From $95, Keeps Buy Rating - marketscreener.com
Ventas Inc (VTR) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Lifestyle hook: Vermilion Energy’s VET dividend as an income product - AD HOC NEWS
Lifestyle angle: why Ventas’ senior housing portfolio matters for VTR investors - AD HOC NEWS
Ventas GC Plans Departure For Blackstone - Law360
Ventas Inc. stock underperforms Monday when compared to competitors - MarketWatch
Ventas, Inc. Announces Executive Changes, Effective June 26, 2026 - marketscreener.com
Three Viable, Buyable, Fast-Growing Senior Housing REITs - Seeking Alpha
Ventas Inc. Stock (US92276F1003): Insider ownership and institutional stakes in focus - AD HOC NEWS
Why Ventas (VTR) is a Great Dividend Stock Right Now - Yahoo Finance
Ventas, Inc. $VTR Stock Holdings Cut by GSI Capital Advisors LLC - MarketBeat
Ventas expects $3.86 FFO per share in 2026 as it raises investment plan to $3B - MSN
Ventas, Inc. acquired The Aston Gardens at Parkland Commons Senior Living Facility in Broward County from Kayne Anderson Capital Advisors, L.P. for $63.8 million. - marketscreener.com
What's in the offing for Ventas stock this earnings season? - MSN
Bank of America Securities Sticks to Their Buy Rating for Ventas (VTR) - The Globe and Mail
O Shaughnessy Asset Management LLC Lowers Position in Ventas, Inc. $VTR - MarketBeat
Deutsche Bank AG Purchases 27,688 Shares of Ventas, Inc. $VTR - MarketBeat
BofA Securities Maintains Ventas Inc(VTR.US) With Buy Rating, Maintains Target Price $110 - Moomoo
Top 3 Real Estate Stocks Which Could Rescue Your Portfolio In June - Sahm
Ventas Inc. stock outperforms competitors on strong trading day - MarketWatch
Ventas stock (US92276F1003): healthcare REIT focuses on senior housing and medical offices - AD HOC NEWS
Ventas Inc Stock (US9227931050): Analyst Targets And Valuation Back In Focus After Recent Rally - AD HOC NEWS
Debra A. Cafaro, 55 - Crain's Chicago Business
Is Ventas Inc (VTR) Overvalued After 3.6% Rally? GF Value Says O - GuruFocus
Ventas stock (US92276F1003): Healthcare REIT focus after recent operating updates - AD HOC NEWS
Ventas Announces Second Quarter 2013 Earnings Release Date and Conference Call - AOL.com
How Investors Are Reacting To Ventas (VTR) Reaffirming Its Dividend And Senior Housing Outlook - simplywall.st
Ventas Inc. stock (US92276F1003): Healthcare REIT focuses on senior housing recovery and portfolio o - AD HOC NEWS
A Look At Ventas (VTR) Valuation After Updated Outlook And Dividend Reaffirmation - Yahoo Finance
Ventas Inc stock (US9227931050): Healthcare REIT focuses on senior housing recovery and capital recy - AD HOC NEWS
Ventas, Inc. $VTR Stock Holdings Decreased by TD Asset Management Inc - MarketBeat
Capital World Investors Purchases Shares of 7,677,904 Ventas, Inc. $VTR - MarketBeat
Finanzdaten der Ventas Inc-Aktie (VTR)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.82%
0.25%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):